Metformin May Inhibit Liver Cancer
By Ernie Shannon for EmaxHealth.com
A drug commonly used to treat diabetes, metformin, may be beneficial in preventing liver cancer, according to researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center. Primary liver cancer is an often deadly form of cancer and is rising around the world. It is now the leading cause of cancer-related deaths among American men. The research results appear in the April 2012 issue of Cancer Prevention Research.
Ironically, patients with Type II diabetes have a two- to three-fold increased risk of developing primary liver cancer. Also at risk are obese people with hepatitis or non-alcoholic fatty liver disease (NAFLD). Metformin is derived from French lilac and used to help patients with Type II diabetes. Thanks to the research in Maryland, it is now being studied in connection with the prevention of a variety of cancers.